Use of Angiotensin System Inhibitors is Associated with Immune Activation and Longer Survival in Non-Metastatic Pancreatic Ductal Adenocarcinoma

Use of Angiotensin System Inhibitors is Associated with Immune Activation and Longer Survival in Non-Metastatic Pancreatic Ductal Adenocarcinoma

Saved in:
Bibliographic Details
Published in:Clinical cancer research Vol. 23; no. 19; pp. 5959 - 5969
Main Authors: Liu, Hao, Naxerova, Kamila, Pinter, Matthias, Incio, Joao, Lee, Hang, Shigeta, Kohei, Ho, William, Crain, Jonathan, Jacobson, Alex, Michelakos, Theodoros, Dias-Santos, Daniella, Zanconato, Andrea, Hong, Theodore S, Clark, Jeffrey W, Murphy, Janet E, Ryan, David P, Deshpande, Vikram, Lillemoe, Keith D, Castillo, Carlos Fernandez-del, Downes, Michael, Evans, Ronald M, Michaelson, James, Ferrone, Cristina R, Boucher, Yves, Jain, Rakesh K.
Format: Journal Article
Language:English
Published: 09-06-2017
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:Y.B. and R.K.J. contributed equally to this work.
ISSN:1078-0432
DOI:10.1158/1078-0432.CCR-17-0256